Hepatitis B virus infection and the risk of hepatocellular carcinoma.
about
Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patientsMolecular mechanism of hepatitis B virus-induced hepatocarcinogenesisRecent advances in multidisciplinary management of hepatocellular carcinomaPrevention of hepatocellular carcinoma in patients with chronic hepatitis BHepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophagesEffects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence.Update on occult hepatitis B virus infectionOccult HBV infection: a faceless enemy in liver cancer development.Occult hepatitis B virus and hepatocellular carcinomaLow prevalence of hepatitis B and C virus markers among children and adolescents.Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.Hepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases.Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analoguesSerolological Profile Among HBsAg-Positive Infections in Southeast China: A Community-Based Study.The associated ion between the VDR gene polymorphisms and susceptibility to hepatocellular carcinoma and the clinicopathological features in subjects infected with HBV.Relationship between hepatocellular carcinoma and hepatitis B virus genotype with spontaneous YMDD mutations.Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis.Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors.Antiviral drug resistance increases hepatocellular carcinoma: a prospective decompensated cirrhosis cohort studyPredictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.Hepatitis B Virus Infection can Cause Hepatocellular Carcinoma in Less Advanced Liver Cirrhosis: A Comparative Study of 142 Patients from North IndiaHepatitis B core-based virus-like particles to present heterologous epitopes.Multiple infections and cancer: implications in epidemiology.Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.Transcriptional profiling and co-expression network analysis identifies potential biomarkers to differentiate chronic hepatitis B and the caused cirrhosis.Overexpression of the metastasis-associated gene MTA3 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication.MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis.Identification and characterization of a novel bipartite nuclear localization signal in the hepatitis B virus polymeraseAssociation of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.Hepatitis B virus and hepatitis D virus in blood donors from Argentina: circulation of HBsAg and reverse transcriptase mutants.Commentary with regard to the role of alcohol and cofactors in the development of hepatocellular carcinoma.Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen.Association of Toll-like receptor 3 polymorphisms with chronic hepatitis B and hepatitis B-related acute-on-chronic liver failure.HBV infection increases the risk of pancreatic cancer: a meta-analysis.The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma.Epigenetically silenced long noncoding-SRHC promotes proliferation of hepatocellular carcinoma.Transforming growth factor-β1 and lysophosphatidic acid activate integrin β6 gene promoter in Hep-3B cells.
P2860
Q26766049-1A613402-9E15-4C7E-BAF8-BEF23F0774F6Q26823512-640A3BCB-2242-4C11-9281-196208A19A05Q26863748-6BEAE04B-8D67-45B9-BB46-C6E4FE5DF4F2Q27023997-20127F4D-4C8A-4A57-B4EC-DF5B91F26AE1Q27329614-363CA793-1138-4DAB-8750-2B351B1F4719Q27687423-709FCC6A-1752-499A-BFFC-27150CEC9BC6Q28070317-2D10F6C8-4112-43D3-A7F2-06D7D0C167EFQ33584773-4607F451-516F-4B43-94BE-9DB3CFF56E5EQ33661018-8E678C5A-869F-4C08-9997-B34B27FDBE2CQ33908680-C38E5DBD-DA3C-46B4-B6E1-9A771950A895Q34962165-B73F4DA6-728E-48E7-A319-6F91226684FDQ35274812-C8DC4DE8-54D2-46E3-99C2-70E12261BE4DQ35473087-39863CED-73B7-451C-A083-331E944E9B80Q35668724-5CD85771-4FEC-4B49-A8BE-22E1FDC8A53BQ36661213-912D0CC8-E8B7-4ACC-982F-95360FB9139CQ36746307-6C3A6BAF-2325-4CFB-8F54-7FB34E2F7611Q36975077-783D0E17-E094-4808-864F-5C4FBB0BA08AQ37050654-C5C09CF4-C19A-4B4E-91A6-600AD8AD4BF8Q37087484-C5FCA9FD-F476-46C0-9D22-74F4E0EE9BC5Q37378970-4B0D8F44-6C5D-48A0-A646-39387A9C6B49Q37605957-3A57F65F-5691-44D4-9A62-696DB49B57E6Q37613675-1199E09F-7F78-4487-B2E4-BEF54B92B6ECQ38081969-A15A8008-BCEF-4B1B-B461-BC95A57AE521Q38126931-51F59FDE-11D8-46D4-A833-F47605231FA4Q38174862-B2BEE6B7-6A42-4629-8A47-EEA43102AF90Q38479037-790EA9EC-8962-4F92-825E-5E9A5D5CC93FQ38780794-530EF114-22D5-4E9F-B0FF-76EF620FE5CFQ38837061-0ACB8767-DBBA-4D59-A19A-7A9942F6CD53Q40051813-528460EB-51B2-4DE0-862B-E6EBE5DDB498Q41477279-DD2F8A0B-BC00-4145-8C6B-E7ABF165DD20Q42150362-E7D2434D-5689-4004-A405-55D7671B0F64Q42223486-87C3EB77-B1B0-4AB7-AF45-A1F4A5363EE7Q42251104-0EC76F02-69BB-47F8-BA8F-BB37C5B91140Q43669477-0D67F956-6A53-41F0-96BB-7CD693865AE0Q44610015-4131BF1C-0382-4CE9-A9BD-EEAEC470AC67Q44854167-C872EF7F-9370-47D7-9926-47A46B74838DQ46521107-651226DD-037A-4E68-BF61-1297AB0FA3A9Q53085477-81BFECDF-AC52-461C-A43C-5455C6FE1CD2Q54180290-D1497233-810F-4104-8F82-ECA40779BEE6Q55248001-9BDB1BC5-D468-4D3C-92E4-E77C31D508E1
P2860
Hepatitis B virus infection and the risk of hepatocellular carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Hepatitis B virus infection and the risk of hepatocellular carcinoma.
@ast
Hepatitis B virus infection and the risk of hepatocellular carcinoma.
@en
type
label
Hepatitis B virus infection and the risk of hepatocellular carcinoma.
@ast
Hepatitis B virus infection and the risk of hepatocellular carcinoma.
@en
prefLabel
Hepatitis B virus infection and the risk of hepatocellular carcinoma.
@ast
Hepatitis B virus infection and the risk of hepatocellular carcinoma.
@en
P2860
P356
P1476
Hepatitis B virus infection and the risk of hepatocellular carcinoma.
@en
P2093
Ya-Jun Tan
P2860
P304
P356
10.3748/WJG.V17.I44.4853
P407
P577
2011-11-01T00:00:00Z